ONO-AE3-208
SIGMA/SML2076 - ≥98% (HPLC)
Synonym: 4-
CAS Number: 402473-54-5
Empirical Formula (Hill Notation): C24H21FN2O3
Molecular Weight: 404.43
MDL Number: MFCD13184814
Linear Formula: C24H21FN2O3
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C24H21FN2O3/c1-15(18-1 |
| InChI key | MTDIMKNAJUQTIO-UHFFFAOYSA |
| SMILES string | CC(C1=C(C=CC=C2)C2=C(F)C= |
| solubility | DMSO: 2 mg/mL, clear |
| storage temp. | −20°C |
| Biochem/physiol Actions: | ONO-AE3-208 is an orally active prostaglandin E2 receptor 4 (EP4)-selective antagonist (Ki in nM = 1.3/EP4, 30/EP3, 790/FP and 2400/TP; Ki >10 μM for prostanoid receptors DP, EP1, EP2, IP). Both EP4-/- mice and ONO-AE3-208-treated wild-type mice (10 mg/kg/day in drinking water) are shown to develop severe symptoms (diarrhea, hemoccult, weight loss) in a murine model of DSS-induced colitis. ONO-AE3-208 is also reported to promote ductus arteriosus constriction among fetal and neonatal rats in vivo (10 mg/kg administered orogastrically). In addition, ONO-AE3-208 is demonstrated to effectively inhibit 1 ng/mL IL-1β-induced HUVEC migration in vitro (53% and 75% inhibition by 1 or 10 μM AE3-208, repectively) and block IL-1β (30 ng/Hydron pellet implant)-induced angionesis in mouse corneas in vivo (1 mg/kg/day p.o.). |
| Biochem/physiol Actions: | Orally available prostaglandin E2 receptor 4 (EP4)-selective antagonist with in vitro and in vivo efficacy. |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | −20°C |
| UNSPSC | 12352200 |
